logo-large
  • Browse Categories

Publications by authors named "Floyd E Fox"

Claim this Profile
M
Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors.
David S Hong, Olivier Rixe, Vi K Chiu, Patrick M Forde, Tomislav Dragovich, Floyd E Fox

Clin Cancer Res· February 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study.
Dmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor, Solmaz Sahebjam, Mario Sznol, Floyd E Fox

Clin Cancer Res· September 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diminished expression of the type II receptor for TGFbeta (TGFbetaRII) in T lymphocytes from patients with Sezary syndrome is not due to mutations in the receptor's poly-A tract: limitations of the standard RT-PCR in cDNA sequence analysis of homopolymeric base stretches.
Qian Zhang, Renold J Capocasale, Floyd E Fox, Vahe Bedian, Eric C Vonderheid

Arch Immunol Ther Exp (Warsz)· February 2003


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: